United Therapeutics Corporation SEC Filings https://ir.unither.com/ United Therapeutics Corporation SEC Filings en DEFA14A: Additional proxy soliciting materials - definitive https://ir.unither.com/sec-filings/sec-filing/defa14a/0001104659-19-035765 UNITED THERAPEUTICS CORP Mon, 17 Jun 2019 06:09:00 -0400 United Therapeutics Corporation SEC Filings 25611 4: Statement of changes in beneficial ownership of securities https://ir.unither.com/sec-filings/sec-filing/4/0001127602-19-021547 UNITED THERAPEUTICS CORP Thu, 13 Jun 2019 16:08:30 -0400 United Therapeutics Corporation SEC Filings 25606 4: Statement of changes in beneficial ownership of securities https://ir.unither.com/sec-filings/sec-filing/4/0001127602-19-021010 UNITED THERAPEUTICS CORP Thu, 06 Jun 2019 16:05:46 -0400 United Therapeutics Corporation SEC Filings 25601 4: Statement of changes in beneficial ownership of securities https://ir.unither.com/sec-filings/sec-filing/4/0001127602-19-020294 UNITED THERAPEUTICS CORP Fri, 31 May 2019 16:11:45 -0400 United Therapeutics Corporation SEC Filings 25586 SD: Specialized Disclosure Report https://ir.unither.com/sec-filings/sec-filing/sd/0001104659-19-032176 UNITED THERAPEUTICS CORP Wed, 29 May 2019 06:12:02 -0400 United Therapeutics Corporation SEC Filings 25576 8-K: Report of unscheduled material events or corporate event https://ir.unither.com/sec-filings/sec-filing/8-k/0001104659-19-027279 UNITED THERAPEUTICS CORP Tue, 07 May 2019 06:13:47 -0400 United Therapeutics Corporation SEC Filings 25551 4: Statement of changes in beneficial ownership of securities https://ir.unither.com/sec-filings/sec-filing/4/0001104659-19-027214 UNITED THERAPEUTICS CORP Mon, 06 May 2019 17:36:06 -0400 United Therapeutics Corporation SEC Filings 25541 3: Initial filing by director officer or owner of more than ten percent. https://ir.unither.com/sec-filings/sec-filing/3/0001104659-19-026098 UNITED THERAPEUTICS CORP Wed, 01 May 2019 18:42:27 -0400 United Therapeutics Corporation SEC Filings 25536 8-K: Report of unscheduled material events or corporate event https://ir.unither.com/sec-filings/sec-filing/8-k/0001104659-19-025680 UNITED THERAPEUTICS CORP Wed, 01 May 2019 06:45:07 -0400 United Therapeutics Corporation SEC Filings 25531 10-Q: Quarterly report which provides a continuing view of a company's financial position https://ir.unither.com/sec-filings/sec-filing/10-q/0001104659-19-025656 UNITED THERAPEUTICS CORP Wed, 01 May 2019 06:45:01 -0400 United Therapeutics Corporation SEC Filings 25526